ZHOU Zongke1, HUANG Zeyu1A, YANG Huilin2A, WENG Xisheng3A, LI Ting4A, WANG Guanglin1A, ZHANG Zhiqiang5A, LIU Tao6A, CHEN Yunzheng7*, SHEN Huiyong8*, WU Xinbao4*, SUN Tiansheng9*,
”
(1.四川大学华西医院骨科.成都610041:2.苏州大学附属第一医院骨科，江苏苏州215006；3.中国医学科学院北京协和医 学院北京协和医院骨科，北京100730;4,北京积水潭医院骨科，北京100035:5.山西医科大学第二医院骨科，太原030001; 6.山东大学齐鲁医院青岛分院骨科，青岛266000;7.山东大学齐鲁医院骨科，济南250012；8.中山大学附属第八医院骨 科，广州510120:9.解放军总医院第七医学中心骨科.北京100700; 10.中国人民解放军总医院骨科.北京100853)
中国骨科手术加速康复围手术期氨甲环酸与 抗凝血药应用的专家共识
中国康复技术转化及发展促进会
中国研疗保健国际交流促进会关节疾病防治分会
国家卫生计生委公益性科研专项《关节置换术安全性与效果评价》项目组
周宗科'黄泽宇山杨惠林“翁习生仏李庭仏王光林心张志强必刘涛皿
陈 *唐允 佩震 福"心沈邱慧贵勇兴"吴 "裴新福宝兴"孙天胜
TANG Peifu10*, QIU Guixing3*, PEI Fuxing1*
(1. Department of Orthopedics. West China Hospital, Sichuan University, Chengdu 610041; 2. Department of Orthopedics, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu; 3.Department of Orthopedics, Peking Union Medical College Hospital, CAMS&PUMC, Beijing 100730; 4. Department of Orthopedics. Beijing Ji Shui Tan Hospital. Beijing 100035: 5.Department of Orthopedics, the Second Affiliated I lospilal of Shanxi Medical University, Taiyuan, 030001; 6. Department of Orthopedics, Qingdao Branch. Qilu Hospital of Shandong University, Qingdao 266000; 7. Department of Orthopedics, Qilu Hospital of Shandong University, Jinan 250012: 8. Department of Orthopedics, the Eighth Affiliated Hospital, Sun Yat-Sen University. Guangzhou 510120: 9. Department of Orthopedics, the seventh Medical Center of PLA General Hospital. Beijing 100700: 10.Department of Orthopedics, Chinese PLA General Hospital, Beijing 100853, China)
Expert consensus on the application of Iranexamic acid and anticoagulant for lhe enhanced recovery after orthopedic surgery in China
China Association of Rehabilitation Technology Transformation and Promotion, Joint Surgery Committee of Chinese Research Hospital Association,
《中华骨与关疗外科朵志》2019年2月第12卷第2期
Chinese Journal of Bone and Joint Surgery Vol.12, No 2, Feb. 2019
・专家共识・
文章编号：2095-9958(2019)02-0081 -08 DOI： 10.3969/j.issn.2095-995&2019.02.01
【摘要】骨科手术出血量大，异体输血率高.极大增加了患者围手术期并发症和经济负担.氨甲环酸(TXA)是一种抗纤溶 药物，大量研究均已证实其能有效减少骨科手术围手术期的失血量、降低输血率和并发症发生率。同时骨科大手术患者 是静脉血栓栓塞症(VTE)的高危人群,应用抗凝血药物能有效降低VTE的发生率。如何在骨科手术患者围手术期更好 地应用抗纤溶药与抗凝血药，达到既可减少患者出血量、降低输血率，同时减少患者发生VTE的风险达到止血与抗凝的 平衡，保障医疗安全。通过查阅文献，中国研究型医院学会关节外科学专业委员会和中国康复技术转化及发展促进会组 织专家遵循循证医学原则.经过反复讨论和通讯修改.对骨科手术加速康复围手术期抗纤溶药与抗凝血药应用方案达成 共识，供广大骨科医师在临床工作中参照应用「 【关键词】骨科手术;氨甲环酸;抗凝血药;加速康复
Joint Diseases Prevention and Treatment Branch of China International Exchange and Promotion Association for Medical and Healthcare,
Project Group for the "National Health and Family Pkinning Commissions^ public—benefit project: the safety and effect assessment of joint arthroplasty",